Elyse R. Thakur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elyse R. Thakur has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Laurie Keefer
Division of Gastroenterology Icahn School of Medicine at Mount Sinai New York City New York USA
2 shared publications Alexander C. Ford
University of Leeds Leeds UK
1 shared publication- Baha Moshiree
Division of Gastroenterology, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States of America
1 shared publication - Brooke A. Duarte
Department of Psychiatry & Center for Digestive Health, Section of Gastroenterology & Hepatology, Dartmouth Hitchcock Medical Center, Lebanon, USA
1 shared publication David J. Hass
Yale University School of Medicine New Haven Connecticut USA
1 shared publication- Elizabeth Webb Lampe
Department of Psychological and Brain Sciences Drexel University Philadelphia Pennsylvania USA
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (6) , e70385
Editorial: Bodily Maps of Emotions in Irritable Bowel Syndrome—Implications for Brain–Gut and Gut–Brain Interventions
- 25 June 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (6) , e70385
Open AccessEditorial: Bodily Maps of Emotions in Irritable Bowel Syndrome—Implications for Brain–Gut and Gut–Brain Interventions
- 7 April 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (4) , e70313
A Primer for Discussing Complementary and Integrative Medicine in Gastroenterology Settings
Background: Complementary and integrative medicine interventions have been increasingly utilized among patients with chronic gastrointestinal disorders. However, to date, there is no data on the implementation of these approaches as part of gastroenterology consultations and follow‐up visits, which suggests that gastroenterology professionals may need more guidance on how to routinely engage in discussions about complementary and integrative medicine approaches to promote best practice. Purpose: This article aims to provide practical recommendations for gastroenterology professionals on how to initiate and navigate discussions about the use of complementary and integrative medicine interventions for patients in routine GI practice settings.
- 7 April 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (4) , e70313
A Primer for Discussing Complementary and Integrative Medicine in Gastroenterology Settings
Background: Complementary and integrative medicine interventions have been increasingly utilized among patients with chronic gastrointestinal disorders. However, to date, there is no data on the implementation of these approaches as part of gastroenterology consultations and follow‐up visits, which suggests that gastroenterology professionals may need more guidance on how to routinely engage in discussions about complementary and integrative medicine approaches to promote best practice. Purpose: This article aims to provide practical recommendations for gastroenterology professionals on how to initiate and navigate discussions about the use of complementary and integrative medicine interventions for patients in routine GI practice settings.
- Open Access
- 16 December 2025
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 11 (1) , 37
Mind-Body Interventions for Comorbid Sleep and Gastrointestinal Concerns
Purpose of Review Sleep disturbances are common in individuals with gastrointestinal (GI) disorders. The connection between sleep and GI symptoms is bidirectional and influenced by shared biopsychosocial mechanisms and cognitive-behavioral factors, including alterations in the stress response. Treating sleep disturbances can effectively manage coexisting symptoms. This review explores current research on sleep treatments for GI conditions, emphasizing mind-body interventions that target stress. Recent Findings Both pharmacological and non-pharmacological approaches (e.g., cognitive behavioral therapy for insomnia) benefit patients with sleep disturbance and concomitant GI symptoms; however, they have limitations. Other approaches, including mind-body interventions, may improve sleep quality, reduce GI symptoms, and enhance quality of life. Summary Mind-body interventions can complement other evidence-based approaches for patients with co-morbid sleep disturbance and GI symptoms. However, more rigorous research is warranted to fully understand their benefit. As research evolves, healthcare professionals can guide patients on how to best integrate these approaches into their care.
- 16 December 2025
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 11 (1) , 37
Open AccessMind-Body Interventions for Comorbid Sleep and Gastrointestinal Concerns
Purpose of Review Sleep disturbances are common in individuals with gastrointestinal (GI) disorders. The connection between sleep and GI symptoms is bidirectional and influenced by shared biopsychosocial mechanisms and cognitive-behavioral factors, including alterations in the stress response. Treating sleep disturbances can effectively manage coexisting symptoms. This review explores current research on sleep treatments for GI conditions, emphasizing mind-body interventions that target stress. Recent Findings Both pharmacological and non-pharmacological approaches (e.g., cognitive behavioral therapy for insomnia) benefit patients with sleep disturbance and concomitant GI symptoms; however, they have limitations. Other approaches, including mind-body interventions, may improve sleep quality, reduce GI symptoms, and enhance quality of life. Summary Mind-body interventions can complement other evidence-based approaches for patients with co-morbid sleep disturbance and GI symptoms. However, more rigorous research is warranted to fully understand their benefit. As research evolves, healthcare professionals can guide patients on how to best integrate these approaches into their care.
- 17 September 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (1) , e14915
A systematic review of yoga for the treatment of gastrointestinal disorders
Background: Several studies have reviewed yoga for the treatment of disorders of gut‐brain interaction (DGBI) with most demonstrating a benefit for symptom reduction; however, yoga has been studied beyond DGBI. Purpose: The aim of this systematic review is to provide a comprehensive summary of yoga as treatment for gastrointestinal conditions. Method: We conducted literature searches in PubMed and Embase and included yoga trials of adults with a diagnosis of a gastrointestinal disorders and diseases. Results: We identified 1275 articles; 12 studies were eligible. Most studies compared yoga to controls, for patients with different GI conditions (irritable bowel syndrome, ulcerative colitis, chronic pancreatitis, and gastrointestinal cancer). The type, method, and duration of yoga used varied. Across IBS studies, most demonstrated that yoga improved IBS symptom severity, mood‐related symptoms, and quality of life compared with controls. In one study of inflammatory bowel disease, yoga improved quality of life compared to controls. Two studies of gastrointestinal cancer demonstrated that yoga led to a reduction in sleep disturbance and mood symptoms. One study of chronic pancreatitis found that yoga led to improvements in quality of life, stress, mood changes, alcohol dependence, and appetite. Yoga was generally safe, and no serious adverse events were attributed to the intervention. Conclusion: In conclusion, yoga appears to be safe and has potential to improve functioning across a spectrum of gastrointestinal diseases; however, current studies are limited by heterogeneity and methodological weaknesses. Further research is needed to evaluate the impact of yoga on health outcomes for a broader range of gastrointestinal conditions.
- 17 September 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (1) , e14915
A systematic review of yoga for the treatment of gastrointestinal disorders
Background: Several studies have reviewed yoga for the treatment of disorders of gut‐brain interaction (DGBI) with most demonstrating a benefit for symptom reduction; however, yoga has been studied beyond DGBI. Purpose: The aim of this systematic review is to provide a comprehensive summary of yoga as treatment for gastrointestinal conditions. Method: We conducted literature searches in PubMed and Embase and included yoga trials of adults with a diagnosis of a gastrointestinal disorders and diseases. Results: We identified 1275 articles; 12 studies were eligible. Most studies compared yoga to controls, for patients with different GI conditions (irritable bowel syndrome, ulcerative colitis, chronic pancreatitis, and gastrointestinal cancer). The type, method, and duration of yoga used varied. Across IBS studies, most demonstrated that yoga improved IBS symptom severity, mood‐related symptoms, and quality of life compared with controls. In one study of inflammatory bowel disease, yoga improved quality of life compared to controls. Two studies of gastrointestinal cancer demonstrated that yoga led to a reduction in sleep disturbance and mood symptoms. One study of chronic pancreatitis found that yoga led to improvements in quality of life, stress, mood changes, alcohol dependence, and appetite. Yoga was generally safe, and no serious adverse events were attributed to the intervention. Conclusion: In conclusion, yoga appears to be safe and has potential to improve functioning across a spectrum of gastrointestinal diseases; however, current studies are limited by heterogeneity and methodological weaknesses. Further research is needed to evaluate the impact of yoga on health outcomes for a broader range of gastrointestinal conditions.